|
|
|
Volumn 9, Issue 5, 2006, Pages 347-353
|
|
The impact of parallel chemistry in drug discovery
a
|
|
Author keywords
ADME (absorption, distribution, metabolism and excretion); Automated analysis; Automated synthesis; In silico; Library design; Non combinatorial; Parallel chemistry
|
|
Indexed keywords
2 ALKYLTHIOBENZIMIDAZOLE DERIVATIVE;
ABELSON KINASE INHIBITOR;
BENZIMIDAZOLE DERIVATIVE;
DOPAMINE 2 RECEPTOR;
DOPAMINE 4 RECEPTOR STIMULATING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
N' ALKYLBENZIMIDAZOLE 2 ONE DERIVATIVE;
NOCICEPTIN RECEPTOR;
NOCICEPTIN RECEPTOR AGONIST;
NOCICEPTIN RECEPTOR ANTAGONIST;
OPIATE RECEPTOR;
PIPERIDINE DERIVATIVE;
PROTEIN TYROSINE KINASE INHIBITOR;
UNCLASSIFIED DRUG;
ARTICLE;
AUTOMATION;
CHEMISTRY;
COMPUTER AIDED DESIGN;
COMPUTER MODEL;
DRUG ABSORPTION;
DRUG DESIGN;
DRUG DISTRIBUTION;
DRUG EXCRETION;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG PURIFICATION;
DRUG RECEPTOR BINDING;
DRUG RESEARCH;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TARGETING;
ENZYME INHIBITION;
EXTRAPYRAMIDAL SYMPTOM;
HIGH THROUGHPUT SCREENING;
HUMAN;
NEUROPROTECTION;
NUCLEAR MAGNETIC RESONANCE;
PRODUCTIVITY;
PROTEIN FUNCTION;
STRUCTURE ANALYSIS;
AUTOMATION;
DRUG DESIGN;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
PHARMACOLOGY;
|
|
EID: 33646824373
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (7)
|
